Ex vivo lung perfusion (EVLP) provides a platform for testing therapies but faces challenges in standardizing drug evaluation. At AAPS PharmSci 360, Xuanzi Zhou says digital twins accurately predict ...
At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...
Pharmacist and PhD researcher Hannah Cleary tells us about her work on long-acting injectables (LAIs) to improve drug ...
Hanmi Pharmaceutical has been selected as a key research institution for a government-led national project aimed at ...
In this interview, Karl Box shows how particle drift analysis with flux techniques enhances oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...
In this interview, Karl Box discusses how particle drift analysis using flux tools improves oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...
ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides for non-viral gene therapy delivery.
Study reshapes view of how a common leukemia begins and could point to new therapeutic strategies targeting a common weakness.
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback